Musculo-skeletal abnormalities after jejunoileal bypass

Area of Science:

• Endocrinology
• Gastroenterology
• Rheumatology

Background:

• Jejunoileal bypass surgery is associated with significant gastrointestinal and metabolic complications.
• Osteomalacia and hyperparathyroidism are frequently observed post-surgery, impacting bone health.
• Polyarthralgia is a common adverse effect, sometimes linked to vasculitic skin lesions.

Purpose of the Study:

• To investigate the prevalence and management of bone abnormalities and joint pain following jejunoileal bypass.
• To assess the efficacy of vitamin D3 therapy and identify factors influencing treatment response.
• To explore treatment options for refractory cases and understand potential underlying mechanisms.

Main Methods:

• Retrospective analysis of patient data following jejunoileal bypass.
• Bone biopsy utilized for diagnosing metabolic bone disease.
• Clinical assessment of response to oral 1 alpha hydroxyvitamin D3 and metronidazole therapy.

Main Results:

• A high incidence (54%) of combined osteomalacia and hyperparathyroidism was noted post-bypass.
• Oral 1 alpha hydroxyvitamin D3 effectively reversed bone abnormalities in most patients.
• Bacterial contamination of the excluded loop may impair treatment response.
• Polyarthralgia (13%) was managed with metronidazole, and bypass reversal provided relief in severe instances.

Conclusions:

• Bone biopsy is crucial for diagnosing post-jejunoileal bypass bone disease.
• Vitamin D3 is a primary treatment, but bacterial overgrowth requires consideration.
• Metronidazole and surgical reversal are effective strategies for managing associated polyarthralgia and refractory bone disease.